Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Lineage Cell Therapeutics Inc shares valued at $6,000,000 were purchased by BROADWOOD PARTNERS, L.P. on Jan 27 ’25. At $0.76 per share, BROADWOOD PARTNERS, L.P. acquired 7,894,737 shares. The insider’s holdings grew to 49,560,992 shares worth approximately $24.78 million following the completion of this transaction.
Also, Howe Jill Ann purchased 15,000 shares, netting a total of over 8,850 in proceeds. Following the buying of shares at $0.59 each, the insider now holds 25,500 shares.
Before that, Samuel George A. III had added 15,000 shares to its account. In a trade valued at $9,000, the General Counsel bought Lineage Cell Therapeutics Inc shares for $0.60 each. Upon closing the transaction, the insider’s holdings increased to 15,000 shares, worth approximately $11092.0.
As published in their initiating research note from Craig Hallum on August 20, 2024, Lineage Cell Therapeutics Inc [LCTX] has been a Buy and the price target has been revised to $4. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in early November. As of June 14, 2022, B. Riley Securities has initiated its “Buy” rating for LCTX. Earlier on August 19, 2021, Noble Capital Markets initiated its rating. Their recommendation was “an Outperform” for LCTX stock.
Analyzing LCTX Stock Performance
During the last five days, there has been a surge of approximately 19.55%. Over the course of the year, Lineage Cell Therapeutics Inc shares have dropped approximately -0.84%. Shares of the company reached a 52-week high of $0.7499 on 02/19/25 and a 52-week low of $0.3651 on 04/09/25. A 50-day SMA is recorded $0.5179, while a 200-day SMA reached $0.7210.
Support And Resistance Levels for Lineage Cell Therapeutics Inc (LCTX)
According to the 24-hour chart, there is a support level at 0.4732, which, if violated, would cause prices to drop to 0.4480. In the upper region, resistance lies at 0.5112. The next price resistance is at 0.5240. RSI (Relative Strength Index) is 56.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0372, which suggests the price will decrease in the coming days. Percent R is at 0.45%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
